As of 2025-06-14, the Fair Value of Day One Biopharmaceuticals Inc (DAWN) is -3.41 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 6.69 USD, the upside of Day One Biopharmaceuticals Inc is -150.94%.
With the market price of 6.69 USD and our fair value calculation, Day One Biopharmaceuticals Inc (DAWN) is not a good investment. Investing in DAWN stocks now will result in a potential loss of 150.94%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -40.51 | -170.64 | -142.18 | -188.92 | -95.50 | -127.55 |
| YoY growth | -220.74% | -321.23% | 16.68% | -32.87% | 49.45% | -101.74% |
| Market Cap (mil) | 678.10 |
| P/E | |
| Forward P/E |
| EPS | -0.68 |
| Avg earnings growth rate | -101.74% |
| TTM earnings | -69.08 |